Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
Clinical trial NCT06119217 · COMPLETED
Trial details
- NCT number
- NCT06119217
- Sponsor
- Trishula Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2025-11-17
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.